|RXi Pharmaceuticals continues to gain momentum|
|Wednesday, 13 October 2010 05:09|
Shares of RXi Pharmaceuticals (NASDAQ:RXII) kept pushing higher on Tuesday, finally closing the regular trading session up at $3.21 +0.37 (13.03%) and ticking even higher during after hours trading.
The stock has been picking up volume and it has continued to display very bullish behavior since we reported in September that the company is rumored to be close to a partnership deal with Pfizer.
Why spend that kind of money in this economy unless something good is cooking?
Oh yeah, and call options are way up. Someone thinks this is going much higher.
Disclosure: Long RXII